|
|
||||||||
Eur J Cardiothorac Surg 2003;24:187-191
© 2003 Elsevier Science NL
a Thoracic Surgery Unit, Department of Surgery, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh 11472, Saudi Arabia
b King Faisal Specialist Hospital, Riyadh, Saudi Arabia
c Pediatric Neurology Unit, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
Received 28 September 2002; received in revised form 21 April 2003; accepted 26 April 2003.
* Corresponding author. Tel.: +966-1-467-1920; fax: +966-1-467-9493
e-mail: alkattan{at}ksu.edu.sa
Objectives: We performed this study to evaluate the benefit of thymectomy in children with myasthenia gravis (MG). Methods: Over a period of 15 years from 1986 to 2001, we collected data on 30 children with MG and retrospectively reviewed the outcome of maximal thymectomy. Results: There were 23 females and seven males with a mean age of 13.2 years (range 416). The mean duration of the disease was 19.3 months (range 2144). According to Osserman classification, there were 14 children in class II; 12 in class III; and four children in class IV. One child in class IV required postoperative ventilation and one was re-explored to drain a pericardial effusion secondary to central line leak. We found ectopic thymic tissue in 10 cases (33.3%). During a mean follow-up period of 53.5 months (range 9180), complete remission was noted in 13 children (43.4%) and improvement in 14 (46.6%). The remaining three children (10%) did not improve following surgery. Univariate analysis (P<0.05) showed that ectopic thymic tissue is a significant prognostic factor for outcome. Conclusion: Maximal thymectomy appears to provide a high rate of remission and improvement in children with MG. However, the presence of ectopic thymic tissue has poor prognostic value.
Key Words: Myasthenia gravis Maximal thymectomy Children
This article has been cited by other articles:
![]() |
M. M. Tracy, W. McRae, and J. G. Millichap Graded Response to Thymectomy in Children With Myasthenia Gravis J Child Neurol, April 1, 2009; 24(4): 454 - 459. [Abstract] [PDF] |
||||
![]() |
H. El-Bawab, A. A. Al-Sugair, M. Rafay, W. Hajjar, M. Mahdy, and K. Al-Kattan Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 731 - 736. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |